Open Access
ARTICLE
ICAT mediates the inhibition of stemness and tumorigenesis in acute myeloid leukemia cells induced by 1,25-(OH)D
YULIAN WANG1, LIANLI ZHU1, RONGHAO ZENG2, YUNPING PU3, BAIJIAN CHEN3, YUWEI TAN3, MING HONG2,*, WEIJIA WANG1,2,*
1 Graduate School, Zhuhai Campus of Zunyi Medical University, Zhuhai, 519041, China
2 Department of Advanced Diagnostic and Clinical Medicine, Zhongshan People’s Hospital, Zhongshan, 528403, China
3 Graduate School, Guangdong Medical University, Zhanjiang, 524023, China
* Corresponding Author: MING HONG. Email: 
; WEIJIA WANG. Email: 
Oncology Research https://doi.org/10.32604/or.2024.051746
Received 14 March 2024; Accepted 06 June 2024; Published online 08 July 2024
Abstract
Background: The role of 1,25-dihydroxyvitamin D3 (1,25-(OH)D) in cancer prevention and treatment is an emerging topic of interest. However, its effects on the stemness of acute myeloid leukemia (AML) cells are poorly understood. Methods: The proliferation and differentiation of AML cells (HL60 and NB4) were investigated by the CCK-8 assay, immunocytochemical staining, and flow cytometry. The abilities of HL60 and NB4 cells to form spheres were examined by the cell sphere formation assay. In addition, the levels of stemness-associated markers (SOX2, Nanog, OCT4, and c-Myc) in HL60 and NB4 cells were measured by western blotting and quantitative real-time polymerase chain reaction. Moreover, we obtained β-catenin-interacting protein 1 (ICAT)-knockout and ICAT-overexpressing HL-60 cells using gene editing and lentiviral infection techniques and investigated the role of ICAT in modulating the stemness-inhibiting effects of 1,25-(OH)D using the aforementioned experimental methods. Finally, we validated our findings in vivo using NOD/SCID mice. Results: 1,25-(OH)D inhibited the proliferation and stemness of AML cells (HL60 and NB4) and induced their differentiation into monocytes. Additionally, the knockdown of ICAT in HL60 cells attenuated the inhibitory effects of 1,25-(OH)D on proliferation and stemness and suppressed the expression of stemness markers. Conversely, overexpression of ICAT enhanced the aforementioned inhibitory effects of 1,25-(OH)D. Consistently, in NOD/SCID mice, 1,25-(OH)D suppressed tumor formation by HL-60 cells, and the effects of ICAT knockdown or overexpression on 1,25-(OH)D aligned with the in vitro findings. Conclusion: 1,25-(OH)D inhibits AML cell stemness, possibly through modulation of the ICAT-mediated Wnt/β-catenin signaling pathway.
Keywords
β-catenin–interacting protein 1 (ICAT); 1,25-dihydroxyvitamin D3 (1,25-(OH)D); Acute myeloid leukemia (AML); Stemness
Login
Register
Submit a Paper
Propose a Special lssue
Download PDF
Downloads
Citation Tools
